102 related articles for article (PubMed ID: 4442688)
21. Effects of 2-Br-alpha-Ergocryptine, L-dopa and cyclic imides on serum prolactin in postmenopausal women.
Rozencweig M; Heuson JC; Bila S; L'Hermite M; Robyn C
Eur J Cancer (1965); 1973 Sep; 9(9):657-64. PubMed ID: 4803232
[No Abstract] [Full Text] [Related]
22. Post-coital contraceptive effect of 2-Br-alpha-ergocryptine (CB-154) in the rat.
Corbin A
Experientia; 1974 Nov; 30(11):1358. PubMed ID: 4435192
[No Abstract] [Full Text] [Related]
23. Effects of 2-Br- -ergocryptine on plasma prolactin level and milk yield in cows.
Karg H; Schams D; Reinhardt V
Experientia; 1972 May; 28(5):574-6. PubMed ID: 4557302
[No Abstract] [Full Text] [Related]
24. Proceedings: The luteotrophic and lactogenic activities of prolactin, human chorionic somatomammotrophin and mouse placental extract on mice treated with an ergocornine derivative.
Zumpe N; Blake M; Wilson CA
J Endocrinol; 1974 May; 61(2):LXX. PubMed ID: 4857925
[No Abstract] [Full Text] [Related]
25. Effect of 2-Br- -ergokryptine (CB 154) on lactation in the bitch.
Mayer P; Schütze E
Experientia; 1973 Apr; 29(4):484-5. PubMed ID: 4736097
[No Abstract] [Full Text] [Related]
26. [Inhibition of postpartal lactation with 2-bromo-alpha-ergocryptine].
Gerstner G; Mick R; Reinold E
Wien Med Wochenschr; 1978; 128(22):704-6. PubMed ID: 735109
[No Abstract] [Full Text] [Related]
27. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
[No Abstract] [Full Text] [Related]
28. [Lactation inhibition with 2-Br-alpha-ergocryptine. Clinical trial with 113 puerperas].
Delli Colli R; Orzi C; Graziosi S; Lambertini G
Riv Ital Ginecol; 1977; 58(6):517-21. PubMed ID: 576027
[No Abstract] [Full Text] [Related]
29. [New possibilities of the lactation-arrest in puerperium (author's transl)].
Vachousek J; Cerný V; Chmelík V; Papez L
Cesk Gynekol; 1975 Feb; 40(1):50-2. PubMed ID: 1131903
[No Abstract] [Full Text] [Related]
30. Successful treatment of galactorrhoea and amenorrhoea and subsequent restoration of ovarian function by a new ergot alkaloid 2-brom-alpha-ergocryptine.
Rolland R; Schellekens LA; Lequin RM
Clin Endocrinol (Oxf); 1974 Apr; 3(2):155-66. PubMed ID: 4858165
[No Abstract] [Full Text] [Related]
31. [Attempt to block galactogenesis by methylergobasine].
Guilhem P; Pontonnier A; Monrozies M; Bardenat M; Merle-Béral A
Bull Fed Soc Gynecol Obstet Lang Fr; 1967; 19(3):277-9. PubMed ID: 5584060
[No Abstract] [Full Text] [Related]
32. Effects of ergot alkaloids on pregnancy and lactation in the albino rat.
SOMMER AF; BUCHANAN AR
Am J Physiol; 1955 Feb; 180(2):296-300. PubMed ID: 14361726
[No Abstract] [Full Text] [Related]
33. [Effect of 2-Br-alpha-ergocryptine (CB 154) on the secretion of prolactin in Anguilla].
Olivereau M; Lemoine AM
C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(12):1883-6. PubMed ID: 4201536
[No Abstract] [Full Text] [Related]
34. [Inhibition of prolactin secretion by ergocornine and 2-Br-alpha-ergocryptine: direct action on the hypophysis in culture].
Pasteels JL; Danguy A; Frérotte M; Ectors F
Ann Endocrinol (Paris); 1971; 32(1):188-92. PubMed ID: 5556257
[No Abstract] [Full Text] [Related]
35. Inhibition of mammary dysplasia in estrogen-treated C3H-HeJ female mice by treatment with 2-bromo-alpha-ergocryptine.
Brooks CL; Welsch CW
Proc Soc Exp Biol Med; 1974 Feb; 145(2):484-7. PubMed ID: 4814143
[No Abstract] [Full Text] [Related]
36. [The possibility of inhibition of galactogenesis by a non-hormonal treatment (methylergobasine)].
Keller B; Lévy G
Sem Ther; 1965 Nov; 41(9):507-9. PubMed ID: 5896319
[No Abstract] [Full Text] [Related]
37. Effects of adrenalectomy and-or deficiency of pituitary prolactin secretion on initiation and maintenance of lactation in mice.
Nagasawa H; Yani R
J Endocrinol; 1973 Jul; 58(1):67-73. PubMed ID: 4722539
[No Abstract] [Full Text] [Related]
38. Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys.
Miyamoto T; Battista A; Goldstein M; Fuxe K
J Pharm Pharmacol; 1974 Jun; 26(6):452-4. PubMed ID: 4154991
[No Abstract] [Full Text] [Related]
39. Clinical trial of 2-Br- -ergocryptine (CB154) in advanced breast cancer.
Eur J Cancer (1965); 1972 Apr; 8(2):155-6. PubMed ID: 4561333
[No Abstract] [Full Text] [Related]
40. Inhibition of lactation in mice following feeding with ergot sclerotia [Claviceps fusiformis (Loveless)] from the bulrush millet [Pennisetum typhoides (Staph and Hubbard)] and an alkaloid component.
Mantle PG
Proc R Soc Lond B Biol Sci; 1968 Jul; 170(1021):423-34. PubMed ID: 4385587
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
